{
    "2020-06-12": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Coronavirus",
                        "ABBV",
                        "LLY",
                        "JNJ",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-06",
                "original_text": "The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations",
                "features": {
                    "keywords": [
                        "Biotech",
                        "FDA",
                        "Viela",
                        "IPOs",
                        "Hematology",
                        "Congress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-07",
                "original_text": "Novo Nordisk to Acquire Corvidia Therapeutics for $725M Cash",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Acquire",
                        "Corvidia",
                        "Therapeutics",
                        "$725M",
                        "Cash"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}